India to Pakistan: Primaquine Export Trade Route

The India to Pakistan Primaquine corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $474.3K USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's primaquine manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $158.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with primaquine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 28.2%, placing it at rank #9 among India's top primaquine export destinations globally.

On the import side, key buyers of Indian primaquine in Pakistan include WORLD HEALTH ORGANISATION, DIRECTORATE OF MALARIA CONTROL, TO THE ORDER OF THE MANAGER. WORLD HEALTH ORGANISATION is the single largest importer with 1 shipments valued at $375.2K USD.

India's primaquine exports to Pakistan are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Pakistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, MACLEODS PHARMACEUTICALS LTD, MBA PHARMACEUTICALS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $158.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as primaquine phosphate 15 mg tablets (10x10) and pharmaceutical product (primaquine phosphate tabs i.p 7.5mg)(b.no.ot-2409007 m:9/24,e:8/27)(p:50x10)(t:5 pks), suggesting that buyers in Pakistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, WORLD HEALTH ORGANISATION is the largest importer with 1 shipments worth $375.2K USD — representing 79% of all primaquine imports from India on this route.